为患有多动症的青少年和年轻成年人 (CAE-ADHD) 提供一个定制的药物坚持增强计划:主要结果
Molly McVoy1,2, Salayna M Abdallah2, Emma Church1
1Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Journal of attention disorders
|April 19, 2025
概括
一项新的干预措施,定制依从性增强-ADHD (CAE-ADHD),在改善青少年和年轻成年人的ADHD症状和过渡准备方面显示出希望. 这项试点研究强调了干预措施.
科学领域:
- 神经发育障碍 神经发育障碍
- 心理社会干预措施 心理社会干预
- 青少年和年轻人的健康.
背景情况:
- 注意缺陷/多动障碍 (ADHD) 是一种持续的神经发育状况,需要有效治疗.
- 患有ADHD的青少年和年轻人 (AYA) 在治疗独立性,参与和坚持方面面临着独特的挑战.
- 未经治疗的ADHD可能会产生显著的长期后果.
研究的目的:
- 评估一种新的心理社会干预措施的可行性和有效性,即针对ADHD的AYA进行定制依从性增强-ADHD (CAE-ADHD).
- 提高ADHD管理的独立性,改善AYA的ADHD症状.
- 为了解决这个弱势群体对治疗的参与和坚持的担忧.
主要方法:
- 一个现有的心理社会干预是根据焦点小组和认知采访与ADHD的AYA进行代性修改的.
- 一项试点可行性和有效性研究对12名被诊断患有ADHD的AYA进行了实验.
- 参与者被跟踪了12周,在8周和12周进行评估.
主要成果:
- 观察到高参与者参与度和保留率,会议完成率为93.33%.
- AYAs显示了ADHD症状 (ADHD RS-5) 的改善趋势,以及在过渡准备和ADHD知识方面的统计学显著改善.
- 在这项试点研究中,没有注意到药物坚持的显著变化.
结论:
- CAE-ADHD干预是一种可行的,潜在的有效的心理社会方法,用于患有ADHD的AYA.
- 该干预导致过渡准备和ADHD知识的显著改善.
- 需要进一步的研究来证实疗效,并在更大的试验中探索坚持结果.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
15.5K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.1K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
23
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
23
Drug Therapy
30
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
30
Modeling in Therapy
33
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
33
Autism Spectrum Disorder
36
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
36
Oppositional Defiant Disorder
15
A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
Diagnostic Criteria and...
15
Adrenergic Agonists: Mixed-Action Agents
625
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
625
